Related Experiment Video
Updated: Jul 15, 2026
09:56
A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
Published on: February 21, 2025
De Novo Synthesis in Cancer Immunotherapy: Applications and Prospects
Yang Jin1, Yanfeng Wu1,2, Jianhua Luo1,2
1Basic Medical Science College Naval Medical University Shanghai PR China.
Medcomm
|July 14, 2026
Summary
De novo protein design creates novel proteins for cancer immunotherapy. These engineered proteins enhance immune responses by targeting cancer cells and modulating the tumor microenvironment.
Area of Science:
- Biochemistry
- Immunology
- Biotechnology
Background:
- De novo protein design allows for the creation of novel proteins with tailored functions.
- Cancer immunotherapy aims to harness the immune system to eliminate malignant cells.
- Current cancer immunotherapies face limitations in efficacy and specificity.
Purpose of the Study:
- To review the integration of de novo protein design principles into cancer immunotherapy.
- To explore how rational design enhances specificity, modularity, and adaptability in therapeutic proteins.
- To discuss the potential of de novo proteins in immune checkpoint regulation, cytokine engineering, cellular therapy, and signaling pathway remodeling.
Main Methods:
- Utilizing advanced computational tools for rational protein design.
- Employing synthetic biology techniques for protein engineering.
- Developing precision-engineered chimeric antigen receptor T-cell (CAR-T) constructs.
- Designing bispecific antibodies for targeted immune cell activation.
Main Results:
- De novo designed proteins offer enhanced cytokine engineering and improved cellular immunotherapy efficacy.
- Novel protein constructs demonstrate potential in augmenting antitumor immune responses.
- Strategies address key limitations of existing cancer immunotherapy approaches.
Conclusions:
- Advances in de novo protein design significantly deepen the understanding of its application in cancer immunotherapy.
- Continued research is crucial to overcome existing limitations and fully realize the potential of these novel therapeutic proteins.
Related Concept Videos
01:27Tumor Immunotherapy
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
01:30Cancer Vaccines
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
02:49Cancer Therapies
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...